Impaired expression of cardiac adiponectin in leptin-deficient mice with viral myocarditis

International Heart Journal

Volumn 47, Issue 1, 2006, Pages 107-123

  Takahashi, Takashi ^a   Yu, Fei ^a   Saegusa, Seiichiro ^a   Sumino, Hiroyuki ^b   Nakahashi, Takeshi ^a   Iwai, Kunimitsu ^a   Morimoto, Shigeto ^a   Kurabayashi, Masahiko ^b   Kanda, Tsugiyasu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adiponectin; Cardiomyocyte; Leptin deficiency; Viral myocarditis

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; LEPTIN; MESSENGER RNA; RECOMBINANT LEPTIN; TUMOR NECROSIS FACTOR ALPHA; ADIPONECTIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL DAMAGE; CELL INFILTRATION; DISEASE COURSE; DISEASE SEVERITY; ENCEPHALOMYOCARDITIS VIRUS; FEMALE; HEART MUSCLE CELL; HEART WEIGHT; HISTOPATHOLOGY; IMMUNOREACTIVITY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCORING SYSTEM; VIRUS MYOCARDITIS; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; GENE EXPRESSION; METABOLISM; MYOCARDITIS; VIROLOGY; VIRUS INFECTION;

ADIPONECTIN; ANIMALS; CARDIOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENCEPHALOMYOCARDITIS VIRUS; FEMALE; GENE EXPRESSION; MICE; MICE, INBRED C57BL; MYOCARDITIS; MYOCYTES, CARDIAC; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33344473170     PISSN: 13492365     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.47.107     Document Type: Article

References (30)

1. Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704-11.
2. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993; 92: 2303-12.
3. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Inter Med 1999; 130: 671-80. (Review)
4. Miller KK, Parulekar MS, Schoenfeld E, et al. Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake. J Clin Endocrinol Metab 1998; 83: 2309-12.
5. Murdoch DR, Rooney E, Dargie HJ, Shapiro D, Morton JJ, McMurray JJ. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart 1999; 82: 352-6.
6. Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention study (WOSCOPS). Circulation 2001; 104: 3052-6.
7. Makris TY, Stavroulakis GA, Krespi PG, et al. Elevated plasma immunoreactive leptin levels preexist in healthy offspring of patients with essential hypertension. Am Heart J 1999; 138: 922-5.
8. Kanda T, Takahashi T, Kudo S, Takeda T, Tsugawa H, Takekoshi N. Leptin deficiency enhances myocardial necrosis and lethality in a murine model of viral myocarditis. Life Sci 2004; 75: 1435-47.
9. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697-703.
10. Yamauchi T, Kamon J, Waki H, et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 2003; 278: 2461-8.
11. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7: 947-53.
12. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731-7.
13. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288-95.
14. Chan KC, Chou HH, Wu DJ, Wu YL, Huang CN. Diabetes mellitus has an additional effect on coronary artery disease. Jpn Heart J 2004; 45: 921-7.
15. Saito K, Tobe T, Minoshima S, et al. Organization of the gene for gelatin-binding protein (GBP28). Gene 1999; 229: 67-73.
16. Kanda T, Koike H, Arai M, et al. Increased severity of viral myocarditis in mice lacking lymphocyte maturation. Int J Cardiol 1999; 68: 13-22.
17. Yoda-Murakami M, Taniguchi M, Takahashi K, et al. Changes in expression of GBP28/adiponectin in carbon tetrachloride-administered mouse liver. Biochem Biophys Res Commun 2001; 285: 372-7.
18. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107: 671-4.
19. Kanazawa K, Kawashima S, Mikami S, et al. Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. Am J Pathol 1996; 148: 1949-56.
20. Ishikawa Y, Akasaka Y, Ishii T, et al. Changes in the distribution pattern of gelatin-binding protein of 28 kDa (adiponectin) in myocardial remodelling after ischaemic injury. Histopathology 2003; 42: 43-52.
21. Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000; 96: 1723-32.
22. Kumada M, Kihara S, Ouchi N, et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004; 109: 2046-9.
23. Grepin C, Dagnino L, Robitaille L, Haberstroh L, Antakly T, Nemer M. A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol Cell Biol 1994; 14: 3115-29.
24. Delporte ML, El Mkadem SA, Quisquater M, Brichard, SM. Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice. Am J Physiol Endocrinol Metab 2004; 287: E446-53.
25. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-9.
26. Kharroubi I, Rasschaert J, Eizirik DL, Cnop M. Expression of adiponectin receptors in pancreatic β cells. Biochem Biophys Res Commun 2003; 312: 1118-22.
27. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-51. (Review)
28. Takahashi T, Saegusa S, Sumino, H, et al. Adiponectin replacement therapy attenuates myocardial damage in leptin-deficient mice with viral myocarditis. J Int Med Res 2005; 33: 207-14.
29. Bluher S. Ziotopoulou M, Bullen JW Jr, et al. Responsiveness to peripherally administered melanocortins in lean and obese mice. Diabetes 2004; 53: 82-90.
30. Tan GD, Debard C, Funahashi T, et al. Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy. Diabetologia 2005; 48: 1585-9.